| Results summary | View all lists in GO:BiolProc | View all genes in R01AD.profile.ud50 |
|
Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment. enrichment: 1.47-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 202973_X_AT | FAM13A1 | S | family with sequence similarity 13, member A1 | ||||||||||
| 210367_S_AT | PTGES | E | S | prostaglandin E synthase | |||||||||
| 203761_AT | SLA | S | Src-like-adaptor | ||||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 203543_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 207556_S_AT | DGKZ | S | diacylglycerol kinase, zeta 104kDa | ||||||||||
| 205440_S_AT | NPY1R | E | S | neuropeptide Y receptor Y1 | |||||||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 217739_S_AT | PBEF1 | G | C | S | pre-B-cell colony enhancing factor 1 | ||||||||
| 202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 204526_S_AT | TBC1D8 | G | S | TBC1 domain family, member 8 (with GRAM domain) | |||||||||
| 211668_S_AT | PLAU | X | P | S | plasminogen activator, urokinase | ||||||||
| 217838_S_AT | EVL | T | D | X | P | S | Enah/Vasp-like | ||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 205251_AT | PER2 | R | S | period homolog 2 (Drosophila) | |||||||||
| 203108_AT | GPRC5A | S | G protein-coupled receptor, family C, group 5, member A | ||||||||||
| 210214_S_AT | BMPR2 | G | D | P | S | bone morphogenetic protein receptor, type II (serine/threonine kinase) | |||||||
| 36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 203685_AT | BCL2 | G | T | X | S | B-cell CLL/lymphoma 2 | |||||||
| 202670_AT | MAP2K1 | P | S | mitogen-activated protein kinase kinase 1 | |||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 205486_AT | TESK2 | G | P | C | S | testis-specific kinase 2 | |||||||
| 201976_S_AT | MYO10 | S | myosin X | ||||||||||
| 204000_AT | GNB5 | S | guanine nucleotide binding protein (G protein), beta 5 | ||||||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 204924_AT | TLR2 | G | X | S | toll-like receptor 2 | ||||||||
| 208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
| 205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 39402_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||